Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Patients With Uterine Leiomyoma
NCT03400826Phase 2Active, not recruiting
- Sponsor
- Johns Hopkins University
- Start
- Aug 2018
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in uterine leiomyoma, sponsored by Johns Hopkins University. Started Aug 2018; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT03400826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03400826.